L'Hermite-Bal#{233}riaux et al.: Growth hormone assays compared connected to plastic tubing that extended to an adjacent room for sampling, as previously described [2] . Each blood sample was centrifuged at 4 #{176}C without delay, and the resulting plasma samples were frozen and kept at -20 #{176}C until assayed. The protocol was approved by the Ethical Committee of the School of Medicine of the Universit#{233} Libre de Bruxelles, and written informed consent was obtained from all subjects. RIA. PolyclonalRIA with the NIADDK reagentswas performed aspreviouslydescribed [2] . The hGH-RP1 preparation, which is equivalentin potency to the 1stWHO Reference Preparation 80/505, was used as the standard.The detection limit was 0.4 ig/L. The intraassay CVs were 8.1% for GH concentrations of 0.4-1 j.tgfL, 6.1% for 1-5 tg/L, and 7.4% for >5 tgfL. The four GH assayswere alsocompared by "difference plot" analysis [9] :The differencebetween the results of each assay, expressedas a percentageof the mean of the two measurements foran individual sample, i.e.,y = [(x1 -x2)/(x1 + x2)/2]X 100, isplottedagainstthe mean, i.e., x = (x, + x,)/2 [9] .
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Results
A totalof 508 plasma samples were analyzed.In the normal subjects,14% of the resultswere at or below the limit of detection for the RIA, 29% for the IRMA-M, 14% for the IRMA-S, and 0% forthe ICMA. In the obese subjects, GH was undetectable in 38% of plasma samples by the RIA, in 48% by the IRMA-M, in 31% by the IRMA-S, and in 12% by the ICMA. Figure 1 depictsindividual 24-h GH profiles for the normal subjects; Fig.2 illustrates the profiles forthe fourobese patients. For each subject, largelysimilar GH profiles were obtainedwith all four assays. However, the mnterpulse values as well as the peak values tended to be lower with the most sensitive assay, i.e., the ICMA. This was particularly marked in obese subjects (see Fig.  2 , subject 5).
Results were analyzed by matching those from each assay with those from each of the other three methods, to calculate To further analyze relationsbetween the resultsof the different methods, we constructed difference plots for the lower GH range ( 1 ig/L; Fig.4 ). This analysis allowed demonstra- The 24-h GH secretion estimated by the different assays in normal and in obese subjects is shown in Fig. 5 . As expected, GH secretion was markedly lower in the obese than in the normal, nonobese subjects by all assays. The highest values were observed with the IRMA-M, the lowest with the ICMA. The results of the pulse analysis (Table 1) showed that the total number of pulses detected in the profiles from the eight subjects ranged from 65 (IRMA-S) to 82 (ICMA). Only 48 pulses were detected at the same time points by all four methods: 22 pulses in the healthy subjects and 26 in the obese patients. The number of pulses detected by only one assay ranged from 2 to 13, according to the assay used. Surprisingly, 13 pulses were detected only by the RIA, the peak values for these pulses ranging from 0.85 to 2.60 jtg/L. All pulses with a peak ICMA value >0.50 tg/L were detectedby at leastone other method, and allpulseswith a peak ICMA value >1 tg/L were detected by allof the other methods. Considering only the concomitant pulsesdetectedby all four methods, peak ICMA valuesforthe 48 pulsesranged from 0.12 to 34.34 tg/L; moreover, the peak valuesin these pulseswere highlycorrelatedbetween the assays, with R2 ranging from 0.80 (between ICMA and IRMA-M) to 0.99 (between IRMA-S and
IRMA-M).
For the concomitant pulses detected by allfour methods, pulseincrement and amount of GH secreted per pulse measured by each assay were calculated for the group of normal subjectsand for the group of obese patients. As expected,GH secretions were markedly lower in obese than in normal subjects, regardless of the assay used (Table 2 ). In the control group, the highestvalues were observed with the IRMA-M. In the obese group, the highest values were observed with the least sensitive assay,i.e., the RIA. In contrast,the lowest valuesin both groups were observed with the most sensitive assay, i.e., the ICMA.
Discussion
As previouslyshown [10] [11] [12] [13] 
